Clin Res Cardiol (2023). https://doi.org/10.1007/s00392-023-02180-w

Prevalence and prognostic impact of coronary chronic total occlusions in heart failure with mildly reduced ejection fraction
A. Schmitt1, T. Schupp1, M. Reinhardt1, J. Forner1, K. Pumpe1, N. Abel1, K. J. Weidner1, K. A. Mashayekhi2, M. Ayoub3, I. Akin1, M. Behnes1
1I. Medizinische Klinik, Universitätsklinikum Mannheim, Mannheim; 2Innere Medizin und Kardiologie, MediClin Herzzentrum Lahr/Baden, Lahr/Schwarzwald; 3Allgemeine und Interventionelle Kardiologie/Angiologie, Herz- und Diabeteszentrum NRW, Bad Oeynhausen;

Objective: This study aims to investigate the prevalence and prognostic impact of coronary chronic total occlusions (CTO) in patients hospitalized due to heart failure with mildly reduced ejection fraction (HFmrEF). 

Background: There is limited data regarding the prevalence and prognostic impact of CTO in patients with HFmrEF.

Methods: A large retrospective registry was used including all consecutive hospitalized patients with HFmrEF (i.e., left ventricular ejection fraction (LVEF) 41 – 49%) undergoing coronary angiography (CA) from 2016 to 2022 according to current European guidelines. The prognostic impact of patients suffering from CTO was compared to patients without (non-CTO). The primary endpoint was the first cardiovascular re-hospitalization at 36 months. Secondary endpoints comprised heart failure related re-hospitalization and in-hospital mortality. Kaplan-Meier, uni- and multivariable Cox regression analyses were applied for statistics.

Results: From a total of 803 HFmrEF patients, the rate of CA was 39%. The prevalence of CTO was 11% (right coronary artery (RCA) 53%, left anterior descending (LAD) 19%, left circumflex (LCX) 8% and multiple vessel CTO 19%). The rate of CTO-PCI was 36%. HFmrEF patients with at least one CTO were associated with an increased risk of cardiovascular re-hospitalization compared to non-CTO patients (36% vs. 22%; p=0.034; HR=1.883; 95% CI 1.037 – 3.420; p=0.038), which was still significant after multivariable adjustment (HR=2.066; 95% CI 1.053 – 4.054; p=0.035). In contrast, CTO patients were not associated with higher rates of heart failure related re-hospitalization (14% vs 7%; p=0.130; HR=2.091; 95% CI 0.788-5.545; p=0.138) and in-hospital mortality (3% vs 1% ; p=0.509).
Conclusions: HFmrEF patients revealed a lower rate of CA with an according lower rate of CTO of 11% still associated with a higher risk of cardiovascular re-hospitalization.


https://dgk.org/kongress_programme/jt2023/aP2058.html